Interval colorectal cancers in inflammatory bowel disease: The grim statistics and true stories

Gastrointestinal Endoscopy Clinics of North America

Volumn 24, Issue 3, 2014, Pages 337-348

  Sanduleanu, Silvia ^a   Rutter, Matthew D ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^c DURHAM UNIVERSITY   (United Kingdom)

Author keywords

Colonoscopy; Colorectal cancer; Crohn's disease; Inflammatory bowel disease; Interval colorectal cancer; Surveillance; Ulcerative colitis

Indexed keywords

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER STAGING; COLONOSCOPY; COLORECTAL CANCER; ENDOSCOPIC SURGERY; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BOWEL DISEASE; PRIORITY JOURNAL; REVIEW; ADENOCARCINOMA; COLORECTAL NEOPLASMS; COMPLICATION; CROHN DISEASE; DISEASE COURSE; EARLY DIAGNOSIS; MINIMAL RESIDUAL DISEASE; PATHOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PROCEDURES; RISK FACTOR; TIME; ULCERATIVE COLITIS;

ADENOCARCINOMA; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; CROHN DISEASE; DISEASE PROGRESSION; EARLY DETECTION OF CANCER; GUIDELINE ADHERENCE; HUMANS; NEOPLASM, RESIDUAL; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; TIME FACTORS;

EID: 84903373806     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2014.03.001     Document Type: Review

References (47)

1. Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut 2011, 60(5):571-607.
2. Rutter M.D., Riddell R.H. Colorectal dysplasia in inflammatory bowel disease: a clinicopathologic perspective. Clin Gastroenterol Hepatol 2014, 12(3):359-367.
3. Murthy S.K., Kiesslich R. Evolving endoscopic strategies for detection and treatment of neoplastic lesions in inflammatory bowel disease. Gastrointest Endosc 2013, 77(3):351-359.
4. Cairns S.R., Scholefield J.H., Steele R.J., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high-risk groups (update from 2002). Gut 2010, 59(5):666-689.
5. Farraye F.A., Odze R.D., Eaden J., et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138(2):746-774.
6. Kornbluth A., Sachar D.B., Practice Parameters Committee of the American College of Gastroenterology Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice parameters Committee. Am J Gastroenterol 2004, 99(7):1371-1385.
7. Lakoff J., Paszat L.F., Saskin R., et al. Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study. Clin Gastroenterol Hepatol 2008, 10:1117-1121.
8. Brenner H., Chang-Claude J., Seiler C.M., et al. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011, 154(1):22-30.
9. Sanduleanu S., Masclee A.M., Meijer G.A. Interval cancers after colonoscopy: insights and recommendations. Nat Rev Gastroenterol Hepatol 2012, 9(9):550-554.
10. Jess T., Simonsen J., Jørgensen K.T., et al. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology 2012, 143(2):375-381.
11. Kappelman M.D., Farkas D.K., Long M.D., et al. Risk of cancer in patients with inflammatory bowel diseases: a nationwide population-based cohort study with 30 years of follow-up evaluation. Clin Gastroenterol Hepatol 2014, 12(2):265-273.e1.
12. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48(4):526-535.
13. Ekbom A., Helmick C., Zack M., et al. Ulcerative colitis and colorectal cancer. A population-based study. NEngl J Med 1990, 323(18):1228-1233.
14. Mellemkjaer L., Olsen J.H., Frisch M., et al. Cancer in patients with ulcerative colitis. Int J Cancer 1995, 60(3):330-333.
15. Herrinton L.J., Liu L., Levin T.R., et al. Incidence and mortality of colorectal adenocarcinomas in persons with inflammatory bowel disease from 1998 to 2010. Gastroenterology 2012, 143(2):382-389.
16. Prior P., Gyde S.N., Macartney J.C., et al. Cancer morbidity in ulcerative colitis. Gut 1982, 23(6):490-497.
17. Rutter M.D., Saunders B.P., Wilkinson K.H., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130(4):1030-1038.
18. Kudo S., Lambert R., Allen J.I., et al. Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 2008, 68(Suppl 4):S3-S47.
19. Soetikno R., Friedland S., Kaltenbach T., et al. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology 2006, 130:566-576.
20. Hamilton S., Aaltonen L.A. WHO classification of tumours. Pathology and genetics: tumours of the digestive system 2000, IARC, Lyon (France).
21. Bosman F.T., Carneiro F., Hruban R.H., et al. WHO classification of tumours. Pathology and genetics. Tumours of the digestive system 2010, Springer-Verlag, Berlin. 4th edition.
22. Robertson D.J., Lieberman D.A., Winawer S.J., et al. Colorectal cancers soon after colonoscopy: a pooled multicohort analysis. Gut 2013, [Epub ahead of print].
23. Le Clercq C.M., Bouwens M.W., Rondagh E.J., et al. Postcolonoscopy colorectal cancers are preventable: a population-based study. Gut 2013, [Epub ahead of print].
24. Pabby A., Schoen R.E., Weissfeld J.L., et al. Analysis of colorectal cancer occurrence during surveillance colonoscopy in the dietary Polyp Prevention Trial. Gastrointest Endosc 2005, 61(3):385-391.
25. Wang Y.R., Cangemi J.R., Loftus E.V., et al. Rate of early/missed colorectal cancers after colonoscopy in older patients with and without inflammatory bowel disease in the United States. Am J Gastroenterol 2013, 108(3):444-449.
26. Kiesslich R., Fritsch J., Holtmann M., et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 2003, 124(4):880-888.
27. Matsumoto T., Nakamura S., Jo Y., et al. Chromoscopy might improve diagnostic accuracy in cancer surveillance for ulcerative colitis. Am J Gastroenterol 2003, 98:1827-1833.
28. Rutter M.D., Saunders B.P., Schofield G., et al. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004, 53(2):256-260.
29. Wu L., Li P., Wu J., et al. The diagnostic accuracy of chromoendoscopy for dysplasia in ulcerative colitis: meta-analysis of six randomized controlled trials. Colorectal Dis 2012, 14(4):416-420.
30. Subramanian V., Mannath J., Ragunath K., et al. Meta-analysis: the diagnostic yield for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment Pharmacol Ther 2011, 33(3):304-312.
31. Soetikno R., Subramanian V., Kaltenbach T., et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013, 144(7):1349-1352.
32. Sanduleanu S., Rondagh E.J., Masclee A.M. Development of expertise in the detection and classification of nonpolypoid colorectal neoplasia: experience-based data at an academic GI unit. Gastrointest Endosc Clin N Am 2010, 20:449-460.
33. Rondagh E.J., Bouwens M.W., Riedl R.G., et al. Endoscopic appearance of proximal colorectal neoplasms and potential implications for colonoscopy in cancer prevention. Gastrointest Endosc 2013, 75:1218-1225.
34. McGill S.K., Kaltenbach T., Friedland S., et al. The learning curve for detection of non-polypoid (flat and depressed) colorectal neoplasms. Gut 2013, [Epub ahead of print].
35. Odze R.D., Farraye F.A., Hecht J.L., et al. Long-term follow-up after polypectomy for adenoma-like dysplastic lesions in ulcerative colitis. Clin Gastroenterol Hepatol 2004, 2(7):534-541.
36. Kaltenbach T., Friedland S., Maheshwari A., et al. Short- and long-term outcomes of standardized EMR of nonpolypoid (flat and depressed) colorectal lesions> or= 1cm (with video). Gastrointest Endosc 2007, 65(6):857-865.
37. Buchner A.M., Guarner-Argente C., Ginsberg G.G. Outcomes of EMR of defiant colorectal lesions directed to an endoscopy referral center. Gastrointest Endosc 2012, 76(2):255-263.
38. Huang Y., Gong W., Su B., et al. Risk and cause of interval colorectal cancer after colonoscopic polypectomy. Digestion 2012, 86:148-154.
39. Gearry R.B., Wakeman C.J., Barclay M.L., et al. Surveillance for dysplasia in patients with inflammatory bowel disease: a national survey of colonoscopic practice in New Zealand. Dis Colon Rectum 2004, 47(3):314-322.
40. van Rijn A.F., Fockens P., Siersema P.D., et al. Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 2009, 15(2):226-230.
41. Spiegel B.M., Ho W., Esrailian E., et al. Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists. Clin Gastroenterol Hepatol 2009, 7(2):168-174.
42. Velayos F.S., Liu L., Lewis J.D., et al. Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system. Gastroenterology 2010, 139(5):1511-1518.
43. Robinson R.J., Hart A.R., Mayberry J.F. Cancer surveillance in ulcerative colitis: a survey of patients' knowledge. Endoscopy 1996, 28(9):761-762.
44. Eaden J., Abrams K., Shears J., et al. Randomized controlled trial comparing the efficacy of a video and information leaflet versus information leafletalone on patient knowledge about surveillance and cancer risk in ulcerative colitis. Inflamm Bowel Dis 2002, 8(6):407-412.
45. Rubio C.A. Serrated neoplasia and de novo carcinomas in ulcerative colitis: a histological study in colectomy specimens. JGastroenterol Hepatol 2007, 22(7):1024-1031.
46. Srivastava A., Redson M., Farraye F.A., et al. Hyperplastic/serrated polyposis in inflammatory bowel disease: a case series of a previously undescribed entity. Am J Surg Pathol 2008, 32(2):296-303.
47. Voorham Q.J., Carvalho B., Spiertz A.J., et al. Chromosome 5q loss in colorectal flat adenomas. Clin Cancer Res 2012, 18(17):4560-4569.